Evidence map›Paper›PMID 26829016›Full record

ArticlePloS one2016

The Biological Effects of Bilirubin Photoisomers.

Jana Jasprova, Matteo Dal Ben, Eleonora Vianello, Iryna Goncharova, Marie Urbanova, Karolina Vyroubalova, Silvia Gazzin, Claudio Tiribelli, Martin Sticha, Marcela Cerna and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Double versus single intensive phototherapy with LEDs in treatment of neonatal hyperbilirubinemia.Journal of perinatology : official journal of the California Perinatal Association · 2018
    Trial
  3. Trial
  4. Bilirubin: translational perspectives.Pediatric research · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jana JasprovaInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Matteo Dal BenItalian Liver Foundation, CSF, Trieste, Italy.
Eleonora VianelloItalian Liver Foundation, CSF, Trieste, Italy.
Iryna GoncharovaInstitute of Chemical Technology Prague, Prague, Czech Republic.
Marie UrbanovaInstitute of Chemical Technology Prague, Prague, Czech Republic.
Karolina VyroubalovaInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Silvia GazzinItalian Liver Foundation, CSF, Trieste, Italy.
Claudio TiribelliItalian Liver Foundation, CSF, Trieste, Italy.
Martin StichaFaculty of Science, Charles University in Prague, Prague, Czech Republic.
Marcela CernaThe Institute for Mother and Child, Prague, Czech Republic.
Libor VitekInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Charles University · CZFondazione Italiana Fegato · ITUniversity of Chemistry and Technology, Prague · CZÚstav pro Péči o Matku a Dítě · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although phototherapy was introduced as early as 1950's, the potential biological effects of bilirubin photoisomers (PI) generated during phototherapy remain unclear. The aim of our study was to isolate bilirubin PI in their pure forms and to assess their biological effects in vitro. The three major bilirubin PI (ZE- and EZ-bilirubin and Z-lumirubin) were prepared by photo-irradiation of unconjugated bilirubin. The individual photoproducts were chromatographically separated (TLC, HPLC), and their identities verified by mass spectrometry. The role of Z-lumirubin (the principle bilirubin PI) on the dissociation of bilirubin from albumin was tested by several methods: peroxidase, fluorescence quenching, and circular dichroism. The biological effects of major bilirubin PI (cell viability, expression of selected genes, cell cycle progression) were tested on the SH-SY5Y human neuroblastoma cell line. Lumirubin was found to have a binding site on human serum albumin, in the subdomain IB (or at a close distance to it); and thus, different from that of bilirubin. Its binding constant to albumin was much lower when compared with bilirubin, and lumirubin did not affect the level of unbound bilirubin (Bf). Compared to unconjugated bilirubin, bilirubin PI did not have any effect on either SH-SY5Y cell viability, the expression of genes involved in bilirubin metabolism or cell cycle progression, nor in modulation of the cell cycle phase. The principle bilirubin PI do not interfere with bilirubin albumin binding, and do not exert any toxic effect on human neuroblastoma cells.

Indexed as

LightBilirubinCell CycleCell LineCell SurvivalChromatography, High Pressure LiquidCircular DichroismGene Expression RegulationHemeHumansIsomerismKineticsLigandsPhototherapySerum AlbuminSpectrophotometry, UltravioletBilirubinHemeLigandsSerum Albumin

Identifiers

PMID26829016
PMCPMC4735493
OpenAlexW2268259471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.